HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy. - Wikidata - wikimedia - TriplyDB

HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.

HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.

http://www.wikidata.org/entity/Q35216193

about

The gut microbiome in human immunodeficiency virus infection Use of Metatranscriptomics in Microbiome Research The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Intestinal microbiota as modulators of the immune system Microbial translocation and microbiome dysbiosis in HIV-associated immune activation Translocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239.Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection.Gut microbiota in 2015: Prevotella in the gut: choose carefully.Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.Effects of HIV, Immune Deficiency, and Confounding on the Distal Gut Microbiota Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV Infection Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees.Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population.Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection.Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle.Maternal HIV infection influences the microbiome of HIV-uninfected infants.Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens.Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.The respiratory microbiome of HIV-infected individuals.Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.The gut microbiome and HIV-1 pathogenesis: a two-way street.Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria.Modulation of the orodigestive tract microbiome in HIV-infected patients.The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen.Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.Changes of the Intestinal Microbiome-Host Homeostasis in HIV-Infected Individuals - A Focus on the Bacterial Gut Microbiome.Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.Unraveling Interactions between the Microbiome and the Host Immune System To Decipher Mechanisms of Disease.Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial.Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals.

P2860

Q26743543-C8FE62D4-094A-4F5D-A280-723DD1EFD038 Q26749065-081D3A91-8AC1-4B8F-8DB1-D7D973152C3D Q26751265-4DEB9EC6-B2A2-4C80-B40E-7F5599DC3FB2 Q26752371-CD132828-4525-4B22-AAA6-02EFE5E47A21 Q26779142-4AC6A4A4-9DEC-413E-9DF5-76718CD97918 Q30839904-9388873C-F711-4976-821D-199C601BC4D1 Q33694217-BC4A48E3-4559-4B10-9042-5E6A4B35C963 Q33827624-0AB2D723-F539-46A2-B317-0C7C29E56AD5 Q34517656-B7A37621-AD35-437F-A2D1-9BE832085BD8 Q35156136-B9E42DF3-B63C-4460-AC5B-F63DBB8E1B7B Q35589732-8B919266-74FC-49AF-877E-AC8065AAD7CF Q35872112-5E00C3B7-3624-46CC-9A0B-CC783CA14B27 Q35883609-9AD47691-A2AB-46EB-8E27-59AD20350CB2 Q35892944-8DFEDD68-F11F-4500-AB17-C805238E3B07 Q35909605-AE421D42-C7D5-4015-85F3-417AF2A0F0F8 Q35945416-00CF7FED-0831-4289-9FB0-F2D0716F5AFF Q35989400-422B0612-50B4-4B0E-9EF3-5F7BAEF28729 Q36339858-1AF19144-F7D1-4C83-9486-48538D3B4772 Q36654972-3C1BA8A3-EE4A-410C-A230-EDF8F53590A4 Q37014250-7B62A6DF-F8F6-47A9-9CCB-5933EBA1EAEC Q37141323-87ABF6F6-11C1-4BEF-98CD-E67A06162F20 Q37317771-9CBAD187-22F6-4A11-A0E3-7ABE7F403ECF Q37574992-201140A4-4622-495E-BC9A-1D32A12F8540 Q37635172-308C398E-C76A-486E-95D3-91C059E094A8 Q37682227-E9C58998-3850-4FAC-8A99-61B8F6889474 Q38727201-0D3770FB-85B8-44D7-A702-5D8485696F20 Q38878361-AE44CF03-A231-411F-B638-FD98A06F2282 Q38973447-78816CB5-CB71-4C6C-AC65-5EEE86D3ACFC Q38984137-3EB08799-E210-46C4-94DB-C5836A1A0B34 Q39001817-E3D5BAC7-AD1E-481F-BF4D-32E9396FE2FA Q39826701-448F3D2D-9B77-4677-BBDA-8EA06BD66F50 Q40400842-A649DE00-C1A4-47F3-B48A-8BAA043F4DEC Q40567962-0B3FF188-56CB-4FC4-A579-F4D0CD945B94 Q42366790-FA34D07E-D646-446B-9481-6054405451E4 Q42372824-D6CD5443-C12E-4E71-BF6F-E947532747DA Q46286824-A45449FB-A4DB-41DF-835E-586D2F4D6557 Q48091579-B3623FFA-2F69-42E0-8A92-7702A6FEA281 Q52725538-5A78C6C7-E943-4963-9F44-FC80CF22E445 Q55260772-10B9F3DC-BC05-4948-B50C-724576AAF9EE Q55360165-A3A7ED8A-06B1-4388-972B-D29376DCB0F6

P2860

HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.

http://www.wikidata.org/entity/Q35216193

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

HIV-induced alteration in gut ...... cts of antiretroviral therapy.

@ast

HIV-induced alteration in gut ...... cts of antiretroviral therapy.

@en

type

label

HIV-induced alteration in gut ...... cts of antiretroviral therapy.

@ast

HIV-induced alteration in gut ...... cts of antiretroviral therapy.

@en

prefLabel

HIV-induced alteration in gut ...... cts of antiretroviral therapy.

@ast

HIV-induced alteration in gut ...... cts of antiretroviral therapy.

@en

P1433

Q35216193-416B8F4C-7538-4A61-A91D-D33FA926B084

P1476

Q35216193-8788C8DA-9D34-4250-AF52-4CC423C513B9

P2093

Q35216193-0ACBD25D-E479-4B03-A961-79B2AB073D64

Q35216193-0D55C7FB-39AA-4930-889C-F3E3D48D62FA

Q35216193-0E84A5F1-6962-47AB-8767-2308B0C7967B

Q35216193-4AB32346-C398-4D20-BEE8-78801B4B087A

Q35216193-BF10493B-515F-47C2-8E29-F6AFAA2A39D8

P2860

Q35216193-0204B456-83AC-4257-AA12-6FED91DBA72E

Q35216193-1057FDE5-5CB7-4998-AACF-898CFD73E6DF

Q35216193-1940F423-9EC3-409B-9202-495D387809FF

Q35216193-19FEAAD4-A3C3-427C-A23B-C51C9F2A18B3

Q35216193-1ACA1F1F-B1D2-4C85-ABDE-B8D54E5C7FFB

Q35216193-1B119E18-9A02-4FD4-8B29-7D84B19708C4

Q35216193-1E7A81E7-1D80-45B5-BB1A-49AE5417A3D7

Q35216193-2FB1C2CF-94FD-4EB5-BF16-7C1C88FCF581

Q35216193-336942E8-92E2-417B-96B3-25F011097E59

Q35216193-390E8D87-3882-45F6-993B-ABDA7303E582

P304

Q35216193-CE2B1C45-B14B-4DF9-9222-7BCF4A9ED203

P31

Q35216193-66002990-9834-4D7E-83BE-63AC07519B02

P356

Q35216193-2EC02C12-58CB-4051-B319-4A484C11AD96

P433

Q35216193-0036773B-CFCD-439B-A0EA-AFD012A7F6C8

P478

Q35216193-1E9FC52D-29DD-4814-A8F8-D597C10AE51B

P50

Q35216193-87C4B58C-C35B-4BDD-9C6D-6E06DCB011CA

P577

Q35216193-E09BA4A7-0A4C-47CD-9CB1-FA82A6829F16

P5875

Q35216193-960880E6-EE6A-4346-B4F1-25E65530E8C2

P698

Q35216193-D5FC9B35-F135-4D2B-B688-DE47D52716B1

P921

Q35216193-773FE359-4895-4C93-B707-9560EF5C7721

P356

P1433

P1476

HIV-induced alteration in gut ...... cts of antiretroviral therapy.

@en

P2093

Andrew P Fontenot

http://www.w3.org/2001/XMLSchema#string

Brent E Palmer

http://www.w3.org/2001/XMLSchema#string

Charles P Neff

http://www.w3.org/2001/XMLSchema#string

Matthew E Rhodes

http://www.w3.org/2001/XMLSchema#string

Thomas B Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice

Linking long-term dietary patterns with gut microbial enterotypes

QIIME allows analysis of high-throughput community sequencing data

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity

Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota

P304

562-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/GMIC.32132

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Catherine A. Lozupone

P577

2014-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264391645

http://www.w3.org/2001/XMLSchema#string

P698

25078714

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug